中国小儿急救医学
中國小兒急救醫學
중국소인급구의학
CHINESE PEDIATRIC EMERGENCY MEDICINE
2011年
4期
368-370
,共3页
肺炎支原体%肺炎%抗生素%免疫治疗
肺炎支原體%肺炎%抗生素%免疫治療
폐염지원체%폐염%항생소%면역치료
Mycoplasma pneumoniae%Pneumonia%Antibiotic%Immune treatment
肺炎支原体是儿童社区获得性肺炎的常见病原.近年来肺炎支原体肺炎(mycoplasmapneumoniae pneumonia,MPP)的发病率逐年增高,国内外关于难治性MPP的病例报道也明显增多,MPP的治疗成为临床医师关注的热点.本文就MPP的抗生素治疗、免疫治疗及其他辅助治疗进展作一综述.
肺炎支原體是兒童社區穫得性肺炎的常見病原.近年來肺炎支原體肺炎(mycoplasmapneumoniae pneumonia,MPP)的髮病率逐年增高,國內外關于難治性MPP的病例報道也明顯增多,MPP的治療成為臨床醫師關註的熱點.本文就MPP的抗生素治療、免疫治療及其他輔助治療進展作一綜述.
폐염지원체시인동사구획득성폐염적상견병원.근년래폐염지원체폐염(mycoplasmapneumoniae pneumonia,MPP)적발병솔축년증고,국내외관우난치성MPP적병례보도야명현증다,MPP적치료성위림상의사관주적열점.본문취MPP적항생소치료、면역치료급기타보조치료진전작일종술.
Mycoplasma pneumoniae is the common pathogen of community-acquired pneumonia in children. In recent years,the incidence of mycoplasma pneumoniae pneumonia(MPP) has increased year by year. And it is found that case reports about intractable MPP at home and abroad have also significantly increased. The treatments of MPP become the focus in clinical physicians. This paper summarized about progress of MPP in antibiotic therapy,immune therapy and other ancillary treatment.